Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014806 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults
A Phase 2 study, sponsored by Novavax.
- Completed
- Registry status
- Phase 2
- Development phase
- 467
- Enrollment target
NCT01014806: Completed Phase 2 study, sponsored by Novavax.
NCT01014806 is a Phase 2 study that has completed, run by Novavax. The registered enrollment target is 467 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (251% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01014806, a Phase 2 study, has completed, sponsored by Novavax.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 467 participants
- Enrollment target
Study Summary
* To assess the tolerability and safety of a single injection of Influenza VLP Vaccine when administered intramuscularly (IM) at 15 µg and 60 µg HA per each strain. * To assess the immunogenicity of Influenza VLP Vaccine administered at 15 µg and 60 µg HA per strain as measured by hemagglutination inhibition (HAI) antibody titers to each of the component viral strains \[A/Brisbane/59/2007 (H1N1); A/Brisbane/10/2007 (H3N2) and B/Brisbane/60/2008\].
Interventions
- BIOLOGICAL TIV
- BIOLOGICAL Influenza VLP Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 467 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
What the finished NCT01014806 record still lists
NCT01014806 is an interventional study that assigns participants to a tested intervention. The registered 467 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (251% higher).
The record links to 0 conditions, and to 2 interventions - of which TIV is the first listed.
NCT01014806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01014806 about?
NCT01014806 is a clinical study titled "Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults". * To assess the tolerability and safety of a single injection of Influenza VLP Vaccine when administered intramuscularly (IM) at 15 µg and 60 µg HA per each strain. * To assess the immunogenicity of Influenza VLP Vaccine administered at 15 µg and 60 µg HA per strain as measured by hemagglutination i...
What is the current status of trial NCT01014806?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 467 participants. The study started on 2009-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01014806?
The interventions under investigation include: TIV (BIOLOGICAL), Influenza VLP Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01014806?
This trial is sponsored by Novavax, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01014806's enrollment target sits among peer trials
467 80th of 2000 higher than 1,921 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06456554 · 467 participants · NA
Acellular Dermal Matrix Investigation in Breast Reconstruction
- NCT03124303 · 468 participants
Interventions for Postoperative Delirium: Biomarker-3
- NCT03901924 · 468 participants · NA
Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
- NCT04482309 · 468 participants · Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia